Axxcess Wealth Management LLC Boosts Stake in Haleon plc (NYSE:HLN)

Axxcess Wealth Management LLC lifted its holdings in shares of Haleon plc (NYSE:HLN) by 3.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 66,322 shares of the company’s stock after acquiring an additional 2,479 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Haleon were worth $633,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of HLN. Thrivent Financial for Lutherans raised its holdings in Haleon by 69.0% in the third quarter. Thrivent Financial for Lutherans now owns 55,593 shares of the company’s stock valued at $588,000 after acquiring an additional 22,701 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Haleon by 3.1% in the 3rd quarter. PNC Financial Services Group Inc. now owns 211,326 shares of the company’s stock valued at $2,236,000 after purchasing an additional 6,381 shares in the last quarter. Prospera Private Wealth LLC bought a new position in shares of Haleon during the third quarter worth about $57,000. King Luther Capital Management Corp acquired a new position in Haleon in the third quarter worth about $158,000. Finally, Landscape Capital Management L.L.C. bought a new stake in Haleon in the third quarter valued at about $1,794,000. Institutional investors and hedge funds own 6.67% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on HLN shares. Hsbc Global Res downgraded Haleon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Sanford C. Bernstein downgraded shares of Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Haleon in a research note on Monday, March 3rd. Morgan Stanley downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Finally, HSBC reaffirmed a “hold” rating on shares of Haleon in a research report on Wednesday, March 5th. Six equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $10.95.

Haleon Stock Performance

HLN stock opened at $10.29 on Friday. Haleon plc has a 1 year low of $7.99 and a 1 year high of $10.80. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The stock has a market capitalization of $46.56 billion, a price-to-earnings ratio of 30.25, a PEG ratio of 2.82 and a beta of 0.25. The stock’s fifty day moving average is $9.84 and its two-hundred day moving average is $9.88.

Haleon (NYSE:HLN) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The business had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion. On average, research analysts predict that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The firm also recently declared a — dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be issued a dividend of $0.1166 per share. This represents a dividend yield of 1.6%. This is a positive change from Haleon’s previous — dividend of $0.05. The ex-dividend date of this dividend is Friday, April 25th. Haleon’s dividend payout ratio (DPR) is 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.